AstraZeneca acquires rights to potential COPD treatment in deal valued at up to $402M By: Philadelphia Business Journal via Business Journals November 28, 2022 at 10:54 AM EST The global licensing deal also includes exclusive rights for other undisclosed inflammatory and respiratory diseases. Read More >>
